M&A in the Chemical Industry
Navigating Uncertainty While Unlocking Strategic Opportunities
Wolfgang Kazmierowski and Christian Dehm, DC Advisory
Mergers and acquisitions (M&A) are both a driver and a reflection of consolidation in the chemical industry. They allow companies to adapt to a challenging environment, leverage synergies and strengthen their market position. Consolidation in the industry will continue, particularly in segments with persistent margin pressure, but also where investors can benefit from long-term trends such as sustainability and innovation.
The global chemical M&A market is facing a period of significant complexity. Investor confidence has been unsettled by a mix of geopolitical tensions, inflation, and regulatory shifts, creating a cautious environment for dealmaking. While general market sentiment remains mixed, we believe both investors and sellers are active in principle.
Financial sponsors with dry powder are scanning the market for the right opportunities, while several large chemical groups are preparing to divest non-core assets as part of broader portfolio restructuring.
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company

DCAT - Drug, Chemical & Associated Technologies AssociationOne Union St., Suite 208
Robbinsville
US
most read

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0

Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.








